The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Daktarin 2% w/w Cutaneous Powder



Johnson & Johnson (Ireland) LimitedPA0330/048/002

Main Information

Trade NameDaktarin 2% w/w Cutaneous Powder
Active SubstancesMiconazole nitrate
Dosage FormCutaneous powder
Licence HolderJohnson & Johnson (Ireland) Limited
Licence NumberPA0330/048/002

Group Information

ATC CodeD01AC Imidazole and triazole derivatives
D01AC02 miconazole

Status

Authorised/WithdrawnAuthorised
Licence Issued01/04/1977
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back